Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $8.55
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Aug 13, 18 | Janney Montgomery Scott | downgrade | Buy | Neutral |
| Aug 13, 18 | Janney Capital | downgrade | Buy | Neutral |
| Aug 9, 17 | Janney Montgomery Scott | upgrade | Neutral | Buy |
| Aug 9, 17 | Janney Capital | upgrade | Neutral | Buy |
| Jan 18, 17 | Janney Capital | maintain | Neutral | Neutral |
| Jan 18, 17 | Janney Montgomery Scott | maintain | Neutral | Neutral |
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 37.22 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 13.73 | Oscillator | Buy |
| Williams %R (14) | -81.09 | Oscillator | Buy |
| MACD (12, 26, 9) | -0.19 (Hist -0.15) | Oscillator | Strong Sell |
| Average Directional Index (14) | 12.21 (+DI 17.1 / -DI 27.8) | Trend | Neutral |
| EMA 20 | 8.56 | MA | Strong Sell |
| SMA 20 | 8.82 | MA | Strong Sell |
| EMA 50 | 8.70 | MA | Strong Sell |
| SMA 50 | 8.69 | MA | Strong Sell |
| SMA 200 | 8.70 | MA | Strong Sell |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 8-K | Sep 23, 2026 | 2026-09-23 09:19:03 | View |
| 4 | Aug 28, 2026 | 2026-08-28 11:21:31 | View |
| SC 13G/A | Aug 14, 2026 | 2026-08-14 11:19:02 | View |
| 8-K | Aug 11, 2026 | 2026-08-11 06:28:51 | View |
| 10-Q | Aug 11, 2026 | 2026-08-11 06:16:57 | View |
| 8-K | Jul 9, 2026 | 2026-07-09 08:49:05 | View |
| 4 | Jun 26, 2026 | 2026-06-26 13:18:56 | View |
| 4 | Jun 22, 2026 | 2026-06-22 09:27:48 | View |
| SD | May 29, 2026 | 2026-05-29 07:25:42 | View |
| 4 | May 20, 2026 | 2026-05-20 11:17:05 | View |
Proxy statement (DEF 14A) disclosures
FY2023 · 10-K disclosure
FY2023 · 10-K disclosure
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Aug 27, 26 | Mcnair Darrell L | director | G-Gift | 5,600 | — |
| Jun 25, 26 |
| Lyon Samuel |
| officer: President of Union Electric |
| S-Sale |
| 9,500 @ $9.82 |
| $93.27K |
| Jun 18, 26 | Lyon Samuel | officer: President of Union Electric | S-Sale | 547 @ $11.30 | $6.18K |
| May 19, 26 | Mcbrayer Brett | director, officer: Chief Executive Officer | P-Purchase | 3,300 @ $9.03 | $29.79K |
| May 15, 26 | Anderson David George | officer: VP, CFO & Treasurer, Pres. ALS | F-InKind | 1,370 @ $10.85 | $14.86K |
| May 15, 26 | Anderson David George | officer: VP, CFO & Treasurer, Pres. ALS | A-Award | 11,117 | — |
| May 15, 26 | Anderson David George | officer: VP, CFO & Treasurer, Pres. ALS | F-InKind | 2,179 @ $10.85 | $23.64K |
| May 15, 26 | Anderson David George | officer: VP, CFO & Treasurer, Pres. ALS | F-InKind | 2,489 @ $10.85 | $27.01K |
Stock news · updated daily
SKYRIZIÂ (risankizumab) and RINVOQÂ (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2
AP is benefiting from firmer steel demand, rising backlog and restructuring gains, but cyclical markets and inflation remain challenges.
CARNEGIE, Pa.--(BUSINESS WIRE)--Ampco-Pittsburgh Corporation (NYSE: AP) (The “Corporation”) announced today that Brett McBrayer, Ampco Chief Executive Officer, David Anderson, Ampco Vice President and Chief Financial Officer and President of Air and Liquid Systems, and Sam Lyon, President of Union Electric Steel, will present at the Sidoti Small-Cap Virtual Investor Conference September 23, 2026. The Corporation's presentation is scheduled to begin at 1:45 pm ET followed by a Q&A session wi.
Ampco-Pittsburgh is upgraded to Buy as a turnaround accelerates, with demand and backlogs surging, especially in the Air and Liquid Processing segment. Despite rising net debt and thin liquidity, AP's backlog reached $358 million, with a book-to-bill ratio of 1.27x, signaling robust forward demand. Adjusted EBITDA margin improved to 9.49%, and incremental margins in ALP hit 55.4%, supporting reinvestment over debt repayment as the optimal capital allocation.
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today presented results from the pivotal Phase 3 SHASTA-3 and SHASTA-4 studies of plozasiran in adults with sever
AP and NNBR are riding different industrial demand tailwinds, but which looks more compelling now? Let's dive in.
AP's second-quarter 2026 results show stronger profitability, improving orders and a growing backlog despite lower sales and negative free cash flow.
Ampco-Pittsburgh Corporation (AP) Q2 2026 Earnings Call Transcript
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 11, 2026 | 0.08 | 0.07 | Miss -12.5% | $102.9M |
| May 12, 2026 | 0.08 | -0.04 | Miss -150.0% | $108.3M |
| Mar 16, 2026 | 0.08 | -0.17 | Miss -312.5% | $108.8M |
| Nov 12, 2025 | — | 0.04 | — | $108.0M |
| Aug 13, 2025 | — | -0.06 | — | $113.1M |
| May 12, 2025 | — | 0.06 | — | $104.3M |
TTM vs. 5-year historical average (annual ratios)
| Metric | AP | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -2.7x | 16.2x · sector 18.4x | Discount |
| Forward P/E (FY26E) | -13.8x | EPS est. -0.62 | Elevated |
| Price / Book | 5.2x | 1.3x | Elevated |
| Price / Sales | 0.4x | 0.2x | Elevated |
| EV / EBITDA | -12.1x | -1.0x | Elevated |
| Return on equity | -152.7% | — | Weak |
| Gross margin | 15.1% | 17.1% | In line |
| Debt / Equity | 4.57 | 2.07 | Levered |
| Piotroski / Altman Z | 4/9 | Z 0.66 | Distress |
Discounted cash flow model